CAB-01-019

N/A

Report date: 2025/01/26 18:46:11

NME

Base Information

Drug NameCAB-01-019

Drug Alias Namedopamine D4 receptor antagonist (High Point University/National Institutes of Health/Johns Hopkins University/Rowan University)CAB-01-019

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine D4 receptor antagonists

TargetsDopamine D4 receptor

Therapy Area/IndicationsSubstance-Related Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHigh Point University

China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of Health Johns Hopkins University Rowan University +[4]

Inactive CompaniesN/A

Active IndicationsSubstance-Related Disorders

Inactive IndicationsN/A

Other Information

ATC CodeN/A